INVEST IN THE FUTURE OF GENOMIC ANALYSIS
NRGene delivers computational genomic solutions and key traits to improve the performance and sustainability of elite seeds, fish, and food species. NRGene’s DeNovoMAGIC and GenoMAGIC provide the critical tools to manage, analyze, and store the massive amounts of big data generated during genomic research. Both platforms have already been proven successful in unraveling, analyzing, and comparing the most complex and diverse genomes, such as wheat, maize, forestry, and fish.
THE GROWING GENOMICS MARKET
The genomics market of software and services used to analyze DNA and RNA big data is exploding. In 2014, breeding entities spent more than $1.4 billion on products, services, and software related to genomic analysis, with a CAGR >25%. About 70% of the multi billion dollar global seed market is controlled by seven multinational companies investing 18% of their annual income into R&D. By 2018, the genomics investment of these seven multinational companies is expected to reach $1.3 billion.
Genomics use in academia for basic research, IP discovery, and breeding is growing at a CAGR of 38% and is expected to reach $1.25 billion 2018, of which about 25% will be invested in plant genomics.
NRGene already has strong commercial relationships with the world’s largest breeding entities and leading academic institutions and expects those relationships to further strengthen over time.
THE TECHNOLOGY SUPPORTS R&D FROM ACADEMIA TO THE MOST SOPHISTICATED GLOBAL SEED, AGRICULTURAL COMPANIES.
With NRGene’s practical results, researchers can quickly and accurately determine the traits required to meet the ever-growing challenges of delivering the global food supply.
- Proven record in the discovery of genes beneficial for boosting breeding & GM
- Adopted by some of the largest global breeding companies & leading NGO’s
- Solves genomic big data challenges for breeding entities of all sizes
- More than 10 scientific papers accepted for publication in key peer-reviewed journals
- Acknowledged by global genomic leaders in academia
INVESTORS CAN REACH US AT email@example.com